SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $127 | -43.8% | 76,900 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $226 | -99.9% | 76,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $369,000 | +20.6% | 76,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $306,000 | -32.9% | 76,900 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $456,000 | -16.8% | 76,900 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $548,000 | -11.3% | 69,900 | +2.9% | 0.00% | -50.0% |
| Q3 2021 | $618,000 | -21.4% | 67,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $786,000 | 0.0% | 67,900 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $786,000 | -33.7% | 67,900 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,186,000 | +70.6% | 67,900 | -4.8% | 0.00% | +33.3% |
| Q3 2020 | $695,000 | +2.7% | 71,300 | -3.3% | 0.00% | -25.0% |
| Q3 2019 | $677,000 | -57.9% | 73,700 | -51.6% | 0.00% | -50.0% |
| Q2 2019 | $1,608,000 | +56.3% | 152,400 | +168.8% | 0.01% | +33.3% |
| Q1 2019 | $1,029,000 | +110.4% | 56,700 | +22.7% | 0.01% | +100.0% |
| Q4 2018 | $489,000 | -52.5% | 46,200 | -18.5% | 0.00% | -50.0% |
| Q3 2018 | $1,029,000 | +27.2% | 56,700 | -2.6% | 0.01% | +20.0% |
| Q2 2018 | $809,000 | +7.4% | 58,200 | +52.4% | 0.01% | 0.0% |
| Q1 2018 | $753,000 | +258.6% | 38,200 | +4.7% | 0.01% | +150.0% |
| Q1 2016 | $210,000 | -37.5% | 36,500 | +2.2% | 0.00% | -50.0% |
| Q4 2015 | $336,000 | +68.8% | 35,700 | +1.4% | 0.00% | +100.0% |
| Q3 2015 | $199,000 | -46.8% | 35,200 | +4.5% | 0.00% | -50.0% |
| Q2 2015 | $374,000 | -26.4% | 33,700 | +4.0% | 0.00% | -33.3% |
| Q1 2015 | $508,000 | -6.1% | 32,400 | -11.2% | 0.01% | -14.3% |
| Q4 2014 | $541,000 | +25.5% | 36,500 | -8.8% | 0.01% | +16.7% |
| Q3 2014 | $431,000 | -27.7% | 40,000 | +2.6% | 0.01% | -33.3% |
| Q2 2014 | $596,000 | -11.2% | 39,000 | +5.1% | 0.01% | -18.2% |
| Q1 2014 | $671,000 | +38.9% | 37,100 | +8.2% | 0.01% | +37.5% |
| Q4 2013 | $483,000 | +54.3% | 34,300 | +15.1% | 0.01% | +60.0% |
| Q3 2013 | $313,000 | – | 29,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |